MENU
+Compare
SCNX
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$0.61
Change
+$0.06 (+10.91%)
Capitalization
24.72M

SCNX stock forecast, quote, news & analysis

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company... Show more

SCNX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SCNX with price predictions
Nov 28, 2025

Momentum Indicator for SCNX turns negative, indicating new downward trend

SCNX saw its Momentum Indicator move below the 0 level on November 06, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SCNX turned negative on October 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

SCNX moved below its 50-day moving average on October 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SCNX crossed bearishly below the 50-day moving average on November 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where SCNX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SCNX advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.299) is normal, around the industry mean (3.080). P/E Ratio (0.811) is within average values for comparable stocks, (42.226). SCNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.283). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (12.048) is also within normal values, averaging (6.647).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Dividends

SCNX paid dividends on July 24, 2024

Scienture Holdings Inc SCNX Stock Dividends
А quarterly dividend of $1.50 per share was paid with a record date of July 24, 2024, and an ex-dividend date of July 19, 2024. Read more...
A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.6B. The market cap for tickers in the group ranges from 3.29K to 24.7B. JDHIF holds the highest valuation in this group at 24.7B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 13%. PETS experienced the highest price growth at 7%, while HKPD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -96% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 71
Price Growth Rating: 65
SMR Rating: 77
Profit Risk Rating: 95
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
SCNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of an online platform for pharmaceutical purchasers

Industry DrugstoreChains

Profile
Fundamentals
Details